Hunter C. Smith, Chief Financial Officer at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 14,608 shares at $99.42 ($1.5M) on 2026-02-17, disclosed to the SEC on 2026-02-19.
Seasonal sale ($1.5M) by Chief Financial Officer — this insider has traded RYTM in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $99.42 | 1,200 | $119K | 8.1% |
| 2 | $99.42 | 1,200 | $119K | 8.1% |
| 3 | $100.52 | 200 | $20K | 1.4% |
| 4 | $101.70 | 900 | $92K | 6.2% |
| 5 | $103.00 | 1,069 | $110K | 7.4% |
| 6 | $103.00 | 1,069 |
| $110K |
| 7.4% |
| 7 | $103.84 | 200 | $21K | 1.4% |
| 8 | $100.27 | 1,308 | $131K | 8.9% |
| 9 | $100.27 | 1,308 | $131K | 8.9% |
| 10 | $100.92 | 1,692 | $171K | 11.5% |
| 11 | $100.92 | 1,692 | $171K | 11.5% |
| 12 | $102.10 | 800 | $82K | 5.5% |
| 13 | $102.10 | 800 | $82K | 5.5% |
| 14 | $103.28 | 585 | $60K | 4.1% |
| 15 | $103.28 | 585 | $60K | 4.1% |
| Total | $101.26 avg | 14,608 | $1.5M | 100% |
| Filing → |
| RYTM | SELL | 2026-02-06 | $1.4M | — | Filing → |
| RYTM | SELL | 2025-08-14 | $5.1M | — | Filing → |
| RYTM | SELL | 2025-07-11 | $4.8M | — | Filing → |